| Literature DB >> 28753430 |
Aviad Tsherniak1, Francisca Vazquez2, Phil G Montgomery1, Barbara A Weir2, Gregory Kryukov2, Glenn S Cowley1, Stanley Gill2, William F Harrington1, Sasha Pantel1, John M Krill-Burger1, Robin M Meyers1, Levi Ali1, Amy Goodale1, Yenarae Lee1, Guozhi Jiang1, Jessica Hsiao1, William F J Gerath1, Sara Howell1, Erin Merkel1, Mahmoud Ghandi1, Levi A Garraway3, David E Root1, Todd R Golub4, Jesse S Boehm1, William C Hahn5.
Abstract
Most human epithelial tumors harbor numerous alterations, making it difficult to predict which genes are required for tumor survival. To systematically identify cancer dependencies, we analyzed 501 genome-scale loss-of-function screens performed in diverse human cancer cell lines. We developed DEMETER, an analytical framework that segregates on- from off-target effects of RNAi. 769 genes were differentially required in subsets of these cell lines at a threshold of six SDs from the mean. We found predictive models for 426 dependencies (55%) by nonlinear regression modeling considering 66,646 molecular features. Many dependencies fall into a limited number of classes, and unexpectedly, in 82% of models, the top biomarkers were expression based. We demonstrated the basis behind one such predictive model linking hypermethylation of the UBB ubiquitin gene to a dependency on UBC. Together, these observations provide a foundation for a cancer dependency map that facilitates the prioritization of therapeutic targets.Entities:
Keywords: RNAi screens; cancer dependencies; cancer targets; genetic vulnerabilities; genomic biomarkers; precision medicine; predictive modeling; seed effects; shRNA
Mesh:
Substances:
Year: 2017 PMID: 28753430 PMCID: PMC5667678 DOI: 10.1016/j.cell.2017.06.010
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582